Safety and upscaling of remote consulting for long-term conditions in primary health care in Nigeria and Tanzania (REaCH trials): stepped-wedge trials of training, mobile data allowance, and implementation.

Journal: The Lancet. Global health

Volume: 11

Issue: 11

Year of Publication: 2023

Affiliated Institutions:  Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Electronic address: jackie.sturt@kcl.ac.uk. Warwick Medical School, University of Warwick, Coventry, UK; Centre for Health Policy, University of the Witwatersrand, Johannesburg, South Africa. College of Medicine, University of Ibadan Nigeria, Ibadan, Nigeria. College of Medicine, University of Ibadan Nigeria, Ibadan, Nigeria; Department of Epidemiology and Medical Statistics, University of Ibadan Nigeria, Ibadan, Nigeria. School of Medicine, St Francis University College of Health and Allied Sciences, Ifakara, Tanzania. Department of Sociology, University of Ibadan Nigeria, Ibadan, Nigeria. Warwick Medical School, University of Warwick, Coventry, UK. Department of Community Medicine, University of Ibadan Nigeria, Ibadan, Nigeria. Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Abstract summary 

In-person health care poses risks to health workers and patients during pandemics. Remote consultations can mitigate these risks. The REaCH intervention comprised training and mobile data allowance provision for mobile phones to support remotely delivered primary care in Africa compared with no training and mobile data allowance. The aim of this study was to estimate the effects of REaCH among adults with non-communicable diseases on remote and face-to-face consultation rates, patient safety, and trustworthiness of consultations.In these two independent stepped-wedge cluster randomised controlled trials, we enrolled 20 primary care clusters in each of two settings (Oyo State, Nigeria, and Morogoro Region, Tanzania). Eligible clusters had 100 or more patients with diabetes, hypertension, and cardiovascular or pulmonary disease employing five health workers. Clusters were computer-randomised to one of ten (Nigeria) or one of seven (Tanzania) sequences to receive the REaCH intervention. Only outcome assessors were masked. Primary outcomes were consultation, prescription, and investigation rates, and trustworthiness collected monthly for 12 months (Nigeria) and 9 months (Tanzania) from open cohorts. Ten randomly sampled consulting patients per cluster-month completed patient reported outcome measures. This trial was registered with ISRCTN, ISRCTN17941313.Overall, 40 clusters comprising 8776 (Nigeria) and 3246 (Tanzania) patients' open cohort data were analysed (6377 [72·7%] of 8776 females in Nigeria, and 2235 [68·9%] of 3246 females in Tanzania). The mean age of the participants was 55·3 years (SD 13·9) in Nigeria and 59·2 years (14·2) in Tanzania. In Nigeria, no evidence of change in face-to-face consulting rate was observed (rate ratio [RR] 1·06, 95% CI 0·98 to 1·09; p=0·16); however, remote consultations increased four-fold (4·44, 1·34 to >10; p=0·01). In Tanzania, face-to-face (0·94, 0·61 to 1·67; p=0·99) and remote consulting rates (1·17, 0·56 to 5·57; p=0·39) were unchanged. There was no evidence of difference in prescribing rates (Nigeria: 1·05, 0·60 to 1·14; p=0·23; Tanzania: 0·92, 0·60 to 1·67; p=0·97), investigation rates (Nigeria: 1·06, 0·23 to 2·12; p=0·49; Tanzania: 1·15, 0·35 to 1·64; 0·58) or trustworthiness scores (Nigeria: mean difference 0·05, 95% CI -0·45 to 0·42; p=0·89; Tanzania: 0·07, -0·15 to 0·76; p=0·70).REaCH can be implemented and could improve intervention versus control health-care access. Remote consultations appear safe and trustworthy, supporting universal health coverage.The UK Research and Innovation Collective Fund.For the Swahili and Yoruba translations of the abstract see Supplementary Materials section.

Authors & Co-authors:  Sturt Jackie J Griffiths Frances F Ajisola Motunrayo M Akinyemi Joshua Odunayo JO Chipwaza Beatrice B Fayehun Olufunke O Harris Bronwyn B Owoaje Eme E Rogers Rebecca R Pemba Senga S Watson Samuel I SI Omigbodun Akinyinka A

Study Outcome 

Source Link: Visit source

Statistics
Citations : 
Authors :  13
Identifiers
Doi : 10.1016/S2214-109X(23)00411-4
SSN : 2214-109X
Study Population
Females
Mesh Terms
Adult
Other Terms
Study Design
Cohort Study,Case Control Trial,Cross Sectional Study
Study Approach
Country of Study
Niger
Publication Country
England